HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages
SAN FRANCISCO, May 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit...
Reed Kathrein Hagens Berman Immunitybio Inc Biologics License Application Good Manufacturing Practice Hagens Berman Sobol Shapiro Llp
Source: globenewswire.com